SMS Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
SMSPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
SMS Pharmaceuticals has informed the stock exchanges that the trading window for dealing in its shares will remain closed from 1st October 2025 until 48 hours after the declaration of its Q2 and H1 FY26 financial results (for the quarter and half-year ended 30th September 2025). The closure applies to all designated persons and their immediate relatives, as required under SEBI's Insider Trading Regulations and the company's own Code of Conduct. The board meeting date to consider and approve these quarterly results will be announced separately in due course.
This is a routine regulatory disclosure and does not directly affect shareholders. However, it signals that the Q2 FY26 earnings announcement is imminent, which may be a point of interest for investors tracking the company's quarterly performance.